PDT Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,400
Closed -$555K 945
2021
Q3
$555K Sell
2,400
-5,100
-68% -$1.26M 0.04% 453
2021
Q2
$1.72M Sell
7,500
-15,401
-67% -$3.09M 0.11% 289
2021
Q1
$4.28M Sell
22,901
-16,799
-42% -$3.29M 0.31% 111
2020
Q4
$6.7M Sell
39,700
-15,818
-28% -$2.36M 0.45% 30
2020
Q3
$8.22M Sell
55,518
-82
-0.1% -$12.7K 0.54% 27
2020
Q2
$9.13M Buy
+55,600
New +$8.53M 0.62% 12
2018
Q1
Sell
-117,109
Closed -$9.89M 584
2017
Q4
$9.89M Sell
117,109
-155,791
-57% -$13.3M 0.29% 119
2017
Q3
$23.3M Hold
272,900
0.77% 33
2017
Q2
$22.5M Buy
+272,900
New +$22.3M 0.9% 27
2015
Q4
Sell
-157,679
Closed -$13.2M 699
2015
Q3
$13.2M Buy
+157,679
New +$13.3M 0.3% 87
2014
Q1
Sell
-28,137
Closed -$1.44M 1332
2013
Q4
$1.44M Sell
28,137
-220,996
-89% -$11.1M 0.17% 164
2013
Q3
$12.5M Sell
249,133
-728,544
-75% -$38.1M 0.34% 39
2013
Q2
$48M Buy
+977,677
New +$53.2M 1.18% 1

Other funds holding LLY

PDT Partners's LLY Position: Q4 2021 in Review

PDT Partners sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 2,400 shares — an estimated $555K sold.

PDT Partners first reported a position in LLY in Q2 2013 and held it in 13 quarters. The position peaked at $48M in Q2 2013. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • PDT Partners reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • PDT Partners sold 2,400 Eli Lilly shares in Q4 2021, an estimated $555K.
  • PDT Partners first reported a position in Eli Lilly in Q2 2013 and held it in 13 quarters.
  • PDT Partners's Eli Lilly position peaked at $48M in Q2 2013.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.